They represent a new chapter in the gradual conceptual shift in how society approaches obesity from a lifestyle condition to a complex, preventable, and treatable chronic disease. However, the guidelines also state that medication alone cannot solve the global obesity burden. Genetics and environmental factors, such as rising stress levels or increased exposure to processed foods, likely contribute as well
Prescriptions, procedures, and treatment recommendations are provided only when clinically appropriate after medical review
You can message the provider anytime if you have concerns or questions about side effects
For some patients on Medicare with specific preexisting conditions such as a stroke, a myocardial infarction, peripheral artery disease or a BMI greater than 35, the drugs will be available for a $50 copay, a senior administration official said
and limiting distribution of unsafe, non FDA-approved semaglutide
This is why fueling strategy matters so much during GLP-1 therapy
